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the verification of treatment delivery. Using the real-time 
cumulative χ we are able to demonstrate an improved ability 
to identify small but potentially significant positional errors 
when compared to using only the integrated image χ value.  
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Purpose/Objective: Proton computed tomography (CT) has 
been described as a solution to image the proton relative 
stopping power (RSP) of patient tissues and could therefore 
reduce the uncertainty and associated margins of the 
conversion of X-ray CT images to RSP maps. Several studies 
have already demonstrated the capability of proton imaging 
to reconstruct tissue RSP but the quantification of the 
improvement with respect to X-ray CT is still missing. This 
study aimed at quantifying the accuracy of RSP maps 
reconstructed from X-ray and proton CT and their impact on 
the prediction of proton ranges under idealized conditions, 
i.e., perfect detectors for the position and the energy of 
protons and realistic but perfectly known X-ray source and 
flat panel. 
Materials and Methods: We have developed a Monte Carlo 
framework to assess proton CT performances for the main 
steps of a proton therapy treatment planning, i.e., proton or 
X-ray CT acquisition and reconstruction, conversion to RSP 
maps based on the calibration of a tissue phantom, and 
proton dose simulations. The RSP maps obtained from X-ray 
CT images rely on the calibration curve that converts 
Hounsfield units into RSP. Two different approaches (linear 
interpolation and least-squares minimization) were tested to 
determine the impact of this calibration. In-silico pencil 
beams were simulated to a computational phantom on 
various anatomical sites and the proton range was assessed 
on the reference, the proton CT-based and the X-ray CT-
based material maps. 
Results: The imaging dose delivered by a proton CT scanner 
appeared impressively uniform and conformal to the imaging 
beam. Comparison of the RSP maps showed that proton CT 
enables a more precise RSP reconstruction of all anatomical 
sites (Figure 1). The spatial distribution of the RSP deviation 
also shows that the accuracy of proton CT reconstruction is 
more uniform. This weaker tissue dependence could help to 
produce a more robust estimate of the proton range between 
patients. As expected from the RSP reconstruction, proton CT 
gave a more precise estimate of the proton range with a 
mean range deviation of only 0.3%, which was at least 60% 
smaller than the X-ray CT predictions. 
 
Figure 1. Absolute deviation of the RSP for liver, head and 
lungs sites for proton CT (left) and for X-ray CT using a 
linearly interpolated calibration (middle) or a least-squares 
fit (right). 
Conclusions: A Monte Carlo framework has been developed 
to assess the performances of proton CT for the simulation of 
the patient dose in proton therapy. Considering ideal 
detectors performances, the reconstructed RSP maps with 
proton CT were more accurate than the RSP maps obtained 
from X-ray CT images. Proton range calculations based on 
proton CT are therefore both more precise and more uniform 
with a weaker dependence to the spatial distribution of 
tissues. Smaller treatment margins could therefore be used if 
proton CT was available to plan proton therapy. Proton CT 
also benefits from the uniformity of the imaging dose 
distribution and its high conformation to the primary beam 
region.  
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Purpose/Objective: Particle induced x-ray emission (PIXE), 
commonly based on detection of characteristic x-rays upon 
irradiation with a low-energy proton beam, is a useful tool 
for high-sensitivity material analysis of thin samples. We 
propose to investigate the feasibility of proton induced x-ray 
fluorescence (pXRF) for range verification in proton therapy. 
The goal of this work was to demonstrate the feasibility of 
proton-induced x-ray fluorescence CT (pXFCT) imaging of 
gold placed in a phantom by means of experiments and Monte 
Carlo (MC) simulations. 
Materials and Methods: First, proton induced gold x-ray 
fluorescence (pXRF) was measured as a function of gold 
concentration. Vials of 2.2 cm in diameter filled with 0-5% Au 
solutions were irradiated with a 3×1011 220 MeV protons of 7-
mm FWHM. X-ray fluorescence induced by the interaction of 
protons and Au was detected with a 3×3 mm2 CdTe detector 
placed at 90° with respect to the incident proton beam at a 
distance of 45 cm from the vials. Second, a 7-cm diameter 
water phantom containing three 2.2-diameter vials with 3%, 
4%, and 5% Au solutions was imaged with the 7-mm 220 MeV 
proton beam in a 1st generation CT scanning geometry 
(Figure 1a). 21 translational steps spaced by 3 mm at each of 
